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Many claims are made for the long term importance of nutritional exposures in early life, 
but studies that examine the impact of such nutrition on a child’s neurodevelopment often 
measure outcomes too prematurely for robust assessment and before full development of 
cognition. Thus, the linked paper by Verfürden and colleagues (doi:10.1136/BMJ-2021-
065805) is impressive. 1 The researchers tracked 1763 participants in seven randomised 
controlled trials of novel infant formulas, started between 1993 and 2001, and linked 91% of 
the studies to centrally collected, objective, educational outcomes at ages 11 and 16 years. 
These “dormant” trials shared similar timings and outcomes and emanated from the same 
research group as the new linked paper, [Author: correct?]  but several differences made 
meta-analysis impossible; one trial began when the infants were aged 6 months, and not at 
birth, [Author : ok?] two studied preterm infants, one studied small for gestational age term 
infants, and three studied only healthy term infants. Two tested formula milks enriched with a 
long chain polyunsaturated fatty acid (LCPUFA), one of the many breast milk constituents 
with a role in brain development; one tested added iron; two tested formula milks with higher 
macronutrient concentrations; and two tested formulations with added sn-2 palmitate or 
nucleotides, not thought to relate to cognition. 
None of these modified formula milks benefitted recipients’ later school performance in 
maths or English, which was perhaps expected, as effects on early development had not been 
shown previously. Verfürden and colleagues’ new results, however, also discount any new 
benefits arising later in childhood. The authors argue that the original trials were large 
enough to detect a true difference of at least 0.33 standard deviation (SD) scores for 
nationally mandated examinations in maths at age 16 years. It is, however, somewhat 
surprising that the original triallists believed that such limited nutritional enhancements could 
have had such large effects. A difference of 0.33 SD scores is nearly three times the cognitive 
effect of breastfeeding reported by one meta-analysis: 0.13 SD (two time points) after 
adjustment for maternal cognition 2.   
An optimistic approach to the size of an expected effect in a planned trial permits a much 
smaller and less costly study; the numbers needed to detect a difference of 0.33 SD would be 
around 260 participants; to detect 0.13 SD requires 1600. This optimistic approach means 
that individual trials are far more likely to be under-powered to detect true effects, however, 
increasing the risk that the findings will be null. 
A recent large systematic review of formula milk trials by Helfer at al3 found that most 
were funded by industry. The trials were small (median 114 participants) and even among 
those published since 2015, less than half were registered in advance or had a primary 
outcome started in the paper. Without trial registration, researchers can conduct many small 
trials and assess multiple outcomes, then publish only those that find statistically significant 
effects, even though these apparent effects probably occurred by chance. Helfer and 
colleagues’ review found that 80% of studies were at high risk of bias, mainly because of 
selective reporting, with 92% of abstracts mentioning positive findings, despite only 42% of 
trials finding statistically significant differences in a stated primary outcome. 
As well as exaggerating small or chance effects, small studies are less likely to detect true 
adverse effects. Verfürden and colleagues noted that, while none were significant,  
participants in five out of the seven supplemented arms fared slightly worse than controls in 
national maths examinations at age 16 years. Scores for both maths and English were 
significantly lower at age 11 years, though not at 16 years, for participants given enriched 
formula milk in the two LCPUFA trials. This finding is consistent with a meta-analysis by the 
same research group suggesting that adding LCPUFA to formula milk is harmful to 
cognition4. As Verfuden and colleagues note, despite their findings, formula milks are often 
supplemented with the LCPUFA docosahexaenoic acid, and in the European Union this is 
mandatory.5 
Verfürden and colleagues found no differences in cognition associated with iron 
supplementation, but they noted that a previous study found reduced cognition at age 16 
years among children who had received formula milk supplemented with iron6.  Breast milk 
contains little iron, and the likely evolutionary reason for this is that iron in the gut facilitates 
the growth of pathogenic bacteria7.  Manufacturers of formula milk advertise  the addition of 
iron to follow-on milks, which could be interpreted as an advantage of formula milk over 
breast milk.  Given the lack of benefit associated with supplementary iron8 and its possible 
adverse effect on growth9 and now cognition6, it is time to consider whether current 
regulations governing the composition of formula milks need review worldwide10. 
Giving babies infant formula instead of breast milk has been shown convincingly and 
repeatedly to place babies at risk of harm 11.  Recently published evidence suggests a need to 
better regulate research into infant formulas and to ensure that this evidence is used to 
remove unnecessary and potentially harmful nutrients from formula milk, and to prevent 
misleading promotional claims. 
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